Quest Diagnostics (DGX) Change in Cash (2009 - 2026)

Quest Diagnostics has disclosed Change in Cash across 18 years of filings, most recently posting $233.0 million for Q2 2026.

• In Q2 2026, Change in Cash rose 77.86% year-over-year to $233.0 million; the TTM figure through Jun 2026 stood at $307.0 million (up 539.58% YoY), while the FY2025 annual figure was -$129.0 million, up 5.84% from the prior year.
• Change in Cash came in at $233.0 million for Q2 2026 at Quest Diagnostics, up from -$27.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $543.0 million in Q4 2023 to a low of -$385.0 million in Q4 2022.
• Average Change in Cash over 5 years is -$13.7 million, with a median of -$38.0 million recorded in 2023.
• Year-over-year, Change in Cash slumped 322.22% in 2022 and surged 2800.0% in 2024.
• Over 5 years, Change in Cash stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then sank by 139.59% to -$215.0 million in 2024, then jumped by 94.42% to -$12.0 million in 2025, then jumped by 2041.67% to $233.0 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were $233.0 million in Q2 2026, -$27.0 million in Q1 2026, and -$12.0 million in Q4 2025.